» Articles » PMID: 24234805

Recommendations to Prescribe in Complex Older Adults: Results of the CRIteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) Project

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 2013 Nov 16
PMID 24234805
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The occurrence of several geriatric conditions may influence the efficacy and limit the use of drugs prescribed to treat chronic conditions. Functional and cognitive impairment, geriatric syndromes (i.e. falls or malnutrition) and limited life expectancy are common features of old age, which may limit the efficacy of pharmacological treatments and question the appropriateness of treatment. However, the assessment of these geriatric conditions is rarely incorporated into clinical trials and treatment guidelines. The CRIME (CRIteria to assess appropriate Medication use among Elderly complex patients) project is aimed at producing recommendations to guide pharmacologic prescription in older complex patients with a limited life expectancy, functional and cognitive impairment, and geriatric syndromes, and providing physicians with a tool to improve the quality of prescribing, independent of setting and nationality. To achieve these aims, we performed the following: (i) Existing disease-specific guidelines on pharmacological prescription for the treatment of diabetes, hypertension, congestive heart failure, atrial fibrillation and coronary heart disease were reviewed to assess whether they include specific indications for complex patients; (ii) a literature search was performed to identify relevant articles assessing the pharmacological treatment of complex patients; (iii) A total of 19 new recommendations were developed based on the results of the literature search and expert consensus. In conclusion, the new recommendations evaluate the appropriateness of pharmacological prescription in older complex patients, translating the recommendations of clinical guidelines to patients with a limited life expectancy, functional and cognitive impairment, and geriatric syndromes. These recommendations cannot represent substitutes for careful clinical consideration and deliberation by physicians; the recommendations are not meant to replace existing clinical guidelines, but they may be used to help physicians in the prescribing process.

Citing Articles

The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.

Ibrahim K, Cox N, Lim S, Radcliffe E, Lundby C, Prokopidis K BMC Geriatr. 2025; 25(1):158.

PMID: 40055633 PMC: 11887267. DOI: 10.1186/s12877-025-05819-7.


Cross-Cultural Adaptation and Clinical Validation of TIME Criteria to Detect Potentially Inappropriate Medication Use in Older Adults: Methodological Report from the TIME International Study Group.

Bahat G, Erdogan T, Can B, Ozkok S, Ilhan B, Tufan A Drugs Aging. 2024; 42(1):57-67.

PMID: 39688727 DOI: 10.1007/s40266-024-01164-3.


Clinician and Family Caregiver Perspectives on Deprescribing Chronic Disease Medications in Older Nursing Home Residents Near the End of Life.

Schleiden L, Klima G, Rodriguez K, Ersek M, Robinson J, Hickson R Drugs Aging. 2024; 41(4):367-377.

PMID: 38575748 PMC: 11021174. DOI: 10.1007/s40266-024-01110-3.


Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta-analysis.

Prokopidis K, Giannos P, Reginster J, Bruyere O, Petrovic M, Cherubini A J Cachexia Sarcopenia Muscle. 2023; 14(2):671-683.

PMID: 36781175 PMC: 10067503. DOI: 10.1002/jcsm.13190.


Association of personality traits with polypharmacy among community-dwelling older adults in Japan: a cross-sectional analysis of data from the SONIC study.

Yoshida Y, Ishizaki T, Masui Y, Arai Y, Inagaki H, Ogawa M BMC Geriatr. 2022; 22(1):372.

PMID: 35484487 PMC: 9047377. DOI: 10.1186/s12877-022-03069-5.


References
1.
Sebastian J, Tresch D . Use of oral anticoagulants in older patients. Drugs Aging. 2000; 16(6):409-35. DOI: 10.2165/00002512-200016060-00003. View

2.
Bruce D, Davis W, Casey G, Clarnette R, Brown S, Jacobs I . Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009; 52(9):1808-15. DOI: 10.1007/s00125-009-1437-1. View

3.
Colloca G, Tosato M, Vetrano D, Topinkova E, Fialova D, Gindin J . Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study. PLoS One. 2012; 7(10):e46669. PMC: 3463565. DOI: 10.1371/journal.pone.0046669. View

4.
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G . Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):160S-198S. DOI: 10.1378/chest.08-0670. View

5.
Chelliah A, Burge M . Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging. 2004; 21(8):511-30. DOI: 10.2165/00002512-200421080-00003. View